Convatec is a global leader in medical products and technologies, specializing in solutions for chronic condition management. The company has established a strong presence in several key areas, including advanced wound care, ostomy care, continence care, and infusion care. One of their notable innovations is the InnovaMatrix® AC, which is the first porcine placental-derived extracellular matrix (ECM) medical device approved by the FDA for wound management. This technology is designed to enhance healing in various types of wounds, including diabetic foot ulcers and venous leg ulcers, by providing a supportive matrix that promotes tissue regeneration and reduces healing time.

In addition to wound care, Convatec has developed the me+ Companion™ App, which offers practical support for individuals using intermittent catheters, ensuring a smoother experience for users. The company also emphasizes the importance of infection prevention and skin protection in its product offerings, which aim to improve patient outcomes while reducing overall care costs. With a commitment to innovation and quality, Convatec continues to advance its technologies to meet the needs of patients and healthcare providers worldwide.

United Kingdom

At Convatec, #ForeverCaring is our promise to patients & healthcare providers, as we deliver pioneering trusted medical solutions to improve the lives we touch. 

#ForeverConvatec

Convatec

Company Details